---
title: "GRAIL signals 22%-32% 2026 Galleri sales growth while starting Epic Aura integrations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285300772.md"
description: "GRAIL, Inc. reported strong Q1 2026 results with revenue of $40.8 million, driven by over 56,000 Galleri tests sold. The company anticipates 22%-32% sales growth for the year, supported by new integrations with Epic Aura. Despite a net loss of $93.2 million, GRAIL remains optimistic about its market position and upcoming data from significant trials. The management reiterated guidance without updates, focusing on expanding physician adoption and health system engagement."
datetime: "2026-05-06T02:53:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285300772.md)
  - [en](https://longbridge.com/en/news/285300772.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285300772.md)
---

# GRAIL signals 22%-32% 2026 Galleri sales growth while starting Epic Aura integrations

Earnings Call Insights: GRAIL, Inc. (GRAL) Q1 2026 Management View "This quarter, we saw continued strong commercial momentum with expanding physician adoption, increasing engagement across health systems and growth in test volumes" (CEO & Director Robert Ragusa). "GRAIL sold over 56,000 Galleri tests in the first quarter" and "Total Galleri screen...

### Related Stocks

- [GRAL.US](https://longbridge.com/en/quote/GRAL.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead](https://longbridge.com/en/news/286677381.md)
- [GRAIL, Inc. $GRAL Shares Sold by Wesbanco Bank Inc.](https://longbridge.com/en/news/285931791.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)